It has also been proposed that RBP7 may serve as a prognostic biomarker in colon cancer and functionally contributes to the malignant phenotype by promoting epithelial-mesenchymal transition (EMT) and tumor invasion (13). This evidence concerns the gene RBP7 and colonic neoplasm.